Xuan Jiaqi, Feng Weiguo, Wang Jiaye, Wang Ruichen, Zhang Bowen, Bo Letao, Chen Zhe-Sheng, Yang Hui, Sun Leming
School of Life Sciences, Engineering Research Center of Chinese Ministry of Education for Biological Diagnosis, Treatment and Protection Technology and Equipment in Special Environment, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China; Innovation Center NPU Chongqing, Northwestern Polytechnical University, Chongqing 400000, China.
School of Life Science and Technology, Weifang Medical University, Weifang 261053, Shandong, China.
Drug Resist Updat. 2023 May;68:100954. doi: 10.1016/j.drup.2023.100954. Epub 2023 Mar 1.
The problem of drug resistance due to long-term use of antibiotics has been a concern for years. As this problem grows worse, infections caused by multiple bacteria are expanding rapidly and are extremely detrimental to human health. Antimicrobial peptides (AMPs) are a good alternative to current antimicrobials with potent antimicrobial activity and unique antimicrobial mechanisms, which have advantages over traditional antibiotics in fighting against drug-resistant bacterial infections. Currently, researchers have conducted clinical investigations on AMPs for drug-resistant bacterial infections while integrating new technologies in the development of AMPs, such as changing amino acid structure of AMPs and using different delivery methods for AMPs. This article introduces the basic properties of AMPs, deliberates the mechanism of drug resistance in bacteria and the therapeutic mechanism of AMPs. The current disadvantages and advances of AMPs in combating drug-resistant bacterial infections are also discussed. This article provides important insights into the research and clinical application of new AMPs for drug-resistant bacterial infections.
长期使用抗生素导致的耐药性问题多年来一直备受关注。随着这一问题日益严重,多重细菌引起的感染正在迅速蔓延,对人类健康极为有害。抗菌肽(AMPs)是当前抗菌药物的良好替代品,具有强大的抗菌活性和独特的抗菌机制,在对抗耐药细菌感染方面比传统抗生素更具优势。目前,研究人员已针对耐药细菌感染对AMPs进行了临床研究,同时在AMPs的开发中整合了新技术,如改变AMPs的氨基酸结构以及采用不同的AMPs递送方法。本文介绍了AMPs的基本特性,探讨了细菌耐药机制以及AMPs的治疗机制。还讨论了AMPs在对抗耐药细菌感染方面当前存在的缺点和进展。本文为新型AMPs用于耐药细菌感染的研究和临床应用提供了重要见解。